{"id":"https://openalex.org/W2425207169","doi":null,"title":"Nanosuspensions as the most promising approach in nanoparticulate drug delivery systems.","display_name":"Nanosuspensions as the most promising approach in nanoparticulate drug delivery systems.","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W2425207169","mag":"2425207169","pmid":"https://pubmed.ncbi.nlm.nih.gov/14964413"},"language":"en","primary_location":{"id":"pmid:14964413","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14964413","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112986298","display_name":"Gorantla Chandra Sekhara Rao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099853","display_name":"Roland Institute of Pharmaceutical Sciences","ror":"https://ror.org/01vva4430","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210099853"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"G Chandra Sekhara Rao","raw_affiliation_strings":["Pharmaceutics Division, Roland Institute of Pharmaceutical Sciences, Berhampur (Gm.), Orissa, India. gcrao2003@rediffmail.com","Pharmaceutics Division, Roland Institute of Pharmaceutical Sciences, Berhampur (Gm.), Orissa, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutics Division, Roland Institute of Pharmaceutical Sciences, Berhampur (Gm.), Orissa, India. gcrao2003@rediffmail.com","institution_ids":["https://openalex.org/I4210099853"]},{"raw_affiliation_string":"Pharmaceutics Division, Roland Institute of Pharmaceutical Sciences, Berhampur (Gm.), Orissa, India","institution_ids":["https://openalex.org/I4210099853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103753104","display_name":"M. Satish Kumar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Satish Kumar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009936324","display_name":"N. Mathivanan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Mathivanan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5112858082","display_name":"Muddana Eswara Bhanoji Rao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M E Bhanoji Rao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.5662,"has_fulltext":false,"cited_by_count":71,"citation_normalized_percentile":{"value":0.89045073,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"59","issue":"1","first_page":"5","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.5800999999046326,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.5800999999046326,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.2870999872684479,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.05389999970793724,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nanoparticle-suspensions","display_name":"nanoparticle suspensions","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nanoparticle-drug-delivery","display_name":"nanoparticle drug delivery","score":0.7839999794960022},{"id":"https://openalex.org/keywords/colloidal-drug-delivery-systems","display_name":"colloidal drug delivery systems","score":0.8679999709129333},{"id":"https://openalex.org/keywords/solid-lipid-nanoparticles","display_name":"solid lipid nanoparticles","score":0.8349999785423279},{"id":"https://openalex.org/keywords/controlled-drug-delivery","display_name":"controlled drug delivery","score":0.8519999980926514},{"id":"https://openalex.org/keywords/local-drug-delivery","display_name":"local drug delivery","score":0.9390000104904175},{"id":"https://openalex.org/keywords/nanoparticles","display_name":"nanoparticles","score":0.8610000014305115}],"concepts":[{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.8265793323516846},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.7318206429481506},{"id":"https://openalex.org/C199529486","wikidata":"https://www.wikidata.org/wiki/Q7557912","display_name":"Solid lipid nanoparticle","level":3,"score":0.6293949484825134},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.5297418832778931},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.49537479877471924},{"id":"https://openalex.org/C126511603","wikidata":"https://www.wikidata.org/wiki/Q1261145","display_name":"Targeted drug delivery","level":3,"score":0.4260326325893402},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.354123055934906},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2394082248210907},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.20977303385734558}],"mesh":[{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008863","descriptor_name":"Microspheres","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011108","descriptor_name":"Polymers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013535","descriptor_name":"Suspensions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:14964413","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14964413","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"Journal Article"},{"id":"mag:2425207169","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14964413","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2483945021","https://openalex.org/W6911671639","https://openalex.org/W7220149337","https://openalex.org/W36687287","https://openalex.org/W2010908051","https://openalex.org/W4413228259","https://openalex.org/W3125999196","https://openalex.org/W4406250571","https://openalex.org/W7095202904","https://openalex.org/W3212822454"],"abstract_inverted_index":{"Over":[0],"the":[1,24,36],"years,":[2],"controlled":[3],"drug":[4,30,38],"delivery":[5,10,31,39],"as":[6,8,70],"well":[7],"site-specific":[9],"have":[11,49],"made":[12],"considerable":[13],"advances.":[14],"One":[15],"area":[16],"that":[17,47],"contributed":[18],"significantly":[19],"to":[20],"this":[21],"progress":[22],"is":[23],"rapidly":[25],"developing":[26],"field":[27],"of":[28,35],"colloidal":[29,37],"systems.":[32],"Nanoparticles,":[33],"one":[34],"systems,":[40],"may":[41],"enable":[42],"new":[43,65],"possibilities":[44],"for":[45],"therapy":[46],"presently":[48],"not":[50],"been":[51],"investigated.":[52],"Recent":[53],"advances":[54],"in":[55],"nanoparticle":[56],"research":[57],"are":[58],"discussed":[59],"here.":[60],"The":[61],"present":[62],"review":[63],"highlights":[64],"and":[66,72],"upcoming":[67],"developments":[68],"such":[69],"nanosuspensions":[71],"solid":[73],"lipid":[74],"nanoparticles.":[75]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}